Manoj Mammen is a Respiratory physician affiliated with University of Rochester Medical Center. OpenAlex indexes 81 publications with 6,365 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
601 Elmwood Ave.
Rochester, NY 146420001
Telephone
585-275-4161Provider last certified this registry record 2 Mar 2022.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
83.1%Corticosteroid48%Trelegy Ellipta33%Breztri Aerosphere30%Fluticasone Propionate19%Breo Ellipta6%Symbicort6%Arnuity Ellipta6%Part D<11 patientsbeta2-Adrenergic Agonist24.7%Albuterol Sulfate Hfa100%Part D≥43 patients+ 2 more classes in this area
Metabolism & gastrointestinal
11.1%Corticosteroid6.4%Prednisone100%Part D≥18 patientsProton pump inhibitor4.7%Omeprazole100%Part D<11 patientsAnti-infectives
3.3%Macrolide Antimicrobial3.3%Azithromycin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Reply to Wilson <i>et al.</i> : The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution
American Journal of Respiratory and Critical Care Medicine
2025 - Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
American Journal of Respiratory and Critical Care Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Ann Falsey, MD
University of Rochester Medical Center
Louis Constine, MD
University of Rochester Medical Center
Supriya Mohile, MD
University of Rochester Medical Center
Edward Messing, MD
University of Rochester Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”